TY - JOUR
T1 - Results of a survey of infectious disease testing practices by organ procurement organizations in the United States
AU - Domen, Ronald E.
AU - Nelson, Kristine A.
PY - 1997/6/27
Y1 - 1997/6/27
N2 - Background. Information related to infectious disease testing policies and practices of organ procurement organizations in the United States does not currently exist. Methods. A total of 63 organ procurement organizations in the United States were surveyed during May 1996. Participants responded to a detailed questionnaire concerning infectious disease tests performed for tissue and solid organ donors and policies related to the reporting and notification of positive test results. Results. The response rate was 77.8%. The majority of testing is performed by hospital laboratories with an expected turnaround time of 5 hr or less by 71% of organ procurement organizations. Almost all routinely perform screening tests for human immunodeficiency virus, hepatitis C virus, cytomegalovirus, syphilis, human T lymphocyte virus I, and hepatitis B surface antigen. Other tests are performed with greater variability. Although the majority of organ procurement organizations perform confirmatory tests when screening tests are positive, 35% do not perform confirmatory testing or do so only sporadically. There are a wide range of policies concerning the subsequent reporting of positive infectious disease tests and to whom results should be reported. Conclusions. Infectious disease testing policies of organ procurement organizations, particularly for solid organs, demonstrate variability in interpretation and perceived significance of positive test results, the initiation or need for reflex and confirmatory testing, the reporting of positive results, and to whom positive test results should be reported. There is a need for a consistent national policy for appropriate infectious disease testing and reporting of results.
AB - Background. Information related to infectious disease testing policies and practices of organ procurement organizations in the United States does not currently exist. Methods. A total of 63 organ procurement organizations in the United States were surveyed during May 1996. Participants responded to a detailed questionnaire concerning infectious disease tests performed for tissue and solid organ donors and policies related to the reporting and notification of positive test results. Results. The response rate was 77.8%. The majority of testing is performed by hospital laboratories with an expected turnaround time of 5 hr or less by 71% of organ procurement organizations. Almost all routinely perform screening tests for human immunodeficiency virus, hepatitis C virus, cytomegalovirus, syphilis, human T lymphocyte virus I, and hepatitis B surface antigen. Other tests are performed with greater variability. Although the majority of organ procurement organizations perform confirmatory tests when screening tests are positive, 35% do not perform confirmatory testing or do so only sporadically. There are a wide range of policies concerning the subsequent reporting of positive infectious disease tests and to whom results should be reported. Conclusions. Infectious disease testing policies of organ procurement organizations, particularly for solid organs, demonstrate variability in interpretation and perceived significance of positive test results, the initiation or need for reflex and confirmatory testing, the reporting of positive results, and to whom positive test results should be reported. There is a need for a consistent national policy for appropriate infectious disease testing and reporting of results.
UR - http://www.scopus.com/inward/record.url?scp=0030923956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030923956&partnerID=8YFLogxK
U2 - 10.1097/00007890-199706270-00014
DO - 10.1097/00007890-199706270-00014
M3 - Article
C2 - 9210505
AN - SCOPUS:0030923956
SN - 0041-1337
VL - 63
SP - 1790
EP - 1794
JO - Transplantation
JF - Transplantation
IS - 12
ER -